Showing 281–300 of 649 signals
Trade press·fiercepharma.com·Aug 17, 2026·Discontinuation·High materiality
CompaniesAstraZenecaMSDAssetsvolrustomigKeytrudaEnhertuTagrissoOrpathysDiseasesnon-small cell lung cancerHER2-mutant non-squamous NSCLCEGFRm NSCLC
2 sources — primary and 1 also reporting
Related coverage (4) — shares extracted facts, not the same cluster
Trade press·clinicaltrialsarena.com·Aug 17, 2026·Other·Low materiality
CompaniesIQVIA
Trade press·clinicaltrialsarena.com·Aug 17, 2026·Trial readout·High materiality
CompaniesArgenxZai Lab LimitedAssetsVyvgart Hytruloefgartigimod alfa and hyaluronidase-qvfcDiseasesautoimmune myositisimmune-mediated necrotising myopathydermatomyositis
Trade press·clinicaltrialsarena.com·Aug 18, 2026·Commercial·High materiality
CompaniesLeal TherapeuticsEli Lilly and CompanyAssetsLTX-001LTX-002Diseasesschizophreniaamyotrophic lateral sclerosis (ALS)
Trade press·clinicaltrialsarena.com·Aug 18, 2026·Other·Low materiality
Trade press·clinicaltrialsarena.com·Aug 18, 2026·Trial readout·High materiality
CompaniesUnited TherapeuticsAssetsTyvasotreprostinilDiseasesprogressive pulmonary fibrosis
Trade press·news.cancerresearchuk.org·Aug 4, 2026·Other·High materiality
Trade press·news.cancerresearchuk.org·Aug 4, 2026·Other·High materiality
Diseaseslymphoma
Trade press·news.cancerresearchuk.org·Aug 5, 2026·Other·High materiality
Trade press·news.cancerresearchuk.org·Aug 11, 2026·Other·Medium materiality
Trade press·news.cancerresearchuk.org·Aug 17, 2026·Other·High materiality
Trade press·news.cancerresearchuk.org·Aug 18, 2026·Other·High materiality
Diseasescancer
Trade press·news.cancerresearchuk.org·Aug 18, 2026·Other·High materiality
CompaniesCancer Research UKMeyler Campbell
Trade press·aacr.org·Aug 5, 2026·Trial readout·High materiality
CompaniesAACRJazz PharmaceuticalsBeOne Medicines Ltd.Astellas Pharma Inc.Natera, Inc.Roche DiagnosticsAssetszanidatamabtislelizumabzolbetuximabchemotherapy for human epidermal growth factor receptor 2 (HER2)-positive tumorschemotherapy for claudin 18.2 (CLDN18.2)-positive tumorsDiseasesgastroesophageal adenocarcinomalocally advanced gastroesophageal cancer
Trade press·aacr.org·Aug 5, 2026·Other·High materiality
CompaniesAmerican Association for Cancer Research
Trade press·fiercehealthcare.com·Aug 17, 2026·Commercial·High materiality
CompaniesHappy HealthARCH Venture PartnersOpenLoopAssetsHappy RingDiseasesobstructive sleep apneainsomnia
Trade press·fiercehealthcare.com·Aug 17, 2026·Commercial·High materiality
CompaniesWhoopGrailAssetsGrail's multi-cancer detection test
Trade press·fiercehealthcare.com·Aug 18, 2026·Commercial·High materiality
CompaniesHopscotch Primary Care
Trade press·fiercehealthcare.com·Aug 18, 2026·Other·High materiality
CompaniesOregon Health & Science University
Trade press·medpagetoday.com·Aug 18, 2026·Other·High materiality